Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

about

Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.

P2860

Q34111875-D9BB8340-6585-47DB-B4D5-6B007F4FD826

P2860

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

Item

http://www.wikidata.org/entity/Q45868793

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh-hant

name

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@en

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@nl

type

Item

label

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@en

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@nl

prefLabel

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@en

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@nl

P1476

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

@en

P2093

Abdel-Wahab Z

http://www.w3.org/2001/XMLSchema#string

Darrow TL

http://www.w3.org/2001/XMLSchema#string

Seigler HF

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

P304

415-423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327489500200505

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10862182

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

about

P2860

P2860

Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921